---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-036380"
form_type: "8-K"
ticker: "GNPX"
cik: "0001595248"
company_name: "Genprex, Inc."
filed_at: "2025-11-26T23:59:59+00:00"
generated_at: "2026-05-16T16:29:28.924260+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Genprex (GNPX) regains Nasdaq bid price compliance, gets equity exception to Dec 31

## Summary
- Nasdaq Panel confirmed Genprex regained compliance with Minimum Bid Price requirement ($1.00).
- Panel granted exception through Dec 31, 2025 to meet Stockholders' Equity Requirement (Listing Rule 5550(b)(1)).
- Company intends to raise additional capital to regain equity compliance; no assurance financing available on acceptable terms.
- Panel may further extend to Feb 9, 2026 upon request, but no guarantee.

## SEC filing metadata
- accession: 0001437749-25-036380
- form_type: 8-K
- ticker: GNPX
- cik: 0001595248
- company_name: Genprex, Inc.
- filed_at: 2025-11-26T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1595248/000143774925036380/0001437749-25-036380-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1595248/000143774925036380/gnpx20251105_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-036380
- JSON: https://secwatch.observer/filing/0001437749-25-036380.json
- Plain text: https://secwatch.observer/filing/0001437749-25-036380.txt

## Source-grounded claims
- claim_id: 4b37bed6eb9b2c9197b1d49fe381c6eb62ac3dec
  claim: Genprex, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).
  evidence_excerpt: November 25, 2025, the Company was formally notified that (i) the Panel determined that the Company has regained compliance with the Bid Price Requirement; and (ii) the Panel has also approved the Company’s request for an exception until December 31, 2025 to demonstrate long-term compliance with the Stockholders’ Equity Requirement (as extended, the “Exception”). As previously disclosed, upon request by the Company, the Panel has discretion to grant the Company continued listing through February 9, 2026. Pursuant to the Exception, the Company is required to, and fully intends to, provide the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1595248/000143774925036380/0001437749-25-036380-index.htm
- claim_id: 649a725afc137bb255899bd146df42a78e63d2cc
  claim: Genprex, Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).
  evidence_excerpt: November 25, 2025, the Company was formally notified that (i) the Panel determined that the Company has regained compliance with the Bid Price Requirement; and (ii) the Panel has also approved the Company’s request for an exception until December 31, 2025 to demonstrate long-term compliance with the Stockholders’ Equity Requirement (as extended, the “Exception”). As previously disclosed, upon request by the Company, the Panel has discretion to grant the Company continued listing through February 9, 2026. Pursuant to the Exception, the Company is required to, and fully intends to, provide the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1595248/000143774925036380/0001437749-25-036380-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.